Members Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $617K | Buy |
21,990
+179
| +0.8% | +$4.77K | 0.02% | 82 |
|
|
2025
Q4 | $543K | Sell |
21,811
-1,715
| -7% | -$43.2K | 0.02% | 84 |
|
|
2025
Q3 | $599K | Buy |
23,526
+235
| +1% | +$5.8K | 0.02% | 80 |
|
|
2025
Q2 | $565K | Buy |
23,291
+116
| +0.5% | +$2.71K | 0.02% | 74 |
|
|
2025
Q1 | $587K | Buy |
23,175
+467
| +2% | +$12.2K | 0.02% | 65 |
|
|
2024
Q4 | $602K | Sell |
22,708
-1,070
| -4% | -$29K | 0.02% | 58 |
|
|
2024
Q3 | $688K | Buy |
23,778
+874
| +4% | +$25.5K | 0.02% | 54 |
|
|
2024
Q2 | $641K | Sell |
22,904
-48
| -0.2% | -$1.32K | 0.02% | 56 |
|
|
2024
Q1 | $637K | Sell |
22,952
-210
| -0.9% | -$5.83K | 0.02% | 53 |
|
|
2023
Q4 | $667K | Buy |
23,162
+500
| +2% | +$15.1K | 0.02% | 48 |
|
|
2023
Q3 | $727K | Buy |
22,662
+250
| +1% | +$8.84K | 0.02% | 40 |
|
|
2023
Q2 | $822K | Sell |
22,412
-5,262
| -19% | -$205K | 0.02% | 37 |
|
|
2023
Q1 | $1.13M | Buy |
27,674
+1,032
| +4% | +$44.6K | 0.03% | 25 |
|
|
2022
Q4 | $1.36M | Sell |
26,642
-1,200
| -4% | -$57.5K | 0.04% | 26 |
|
|
2022
Q3 | $1.22M | Buy |
27,842
+3,018
| +12% | +$147K | 0.04% | 29 |
|
|
2022
Q2 | $1.3M | Buy |
24,824
+540
| +2% | +$27.5K | 0.04% | 32 |
|
|
2022
Q1 | $1.26M | Sell |
24,284
-770
| -3% | -$40K | 0.04% | 31 |
|
|
2021
Q4 | $1.48M | Sell |
25,054
-362
| -1% | -$17.9K | 0.04% | 32 |
|
|
2021
Q3 | $1.11M | Buy |
25,416
+1,362
| +6% | +$60.3K | 0.03% | 37 |
|
|
2021
Q2 | $942K | Sell |
24,054
-1,236
| -5% | -$48.1K | 0.03% | 44 |
|
|
2021
Q1 | $916K | Sell |
25,290
-2,246
| -8% | -$79.7K | 0.03% | 41 |
|
|
2020
Q4 | $1.01M | Sell |
27,536
-2,253
| -8% | -$82.6K | 0.04% | 36 |
|
|
2020
Q3 | $1.04M | Sell |
29,789
-25,491
| -46% | -$894K | 0.04% | 32 |
|
|
2020
Q2 | $1.72M | Buy |
+55,280
| New | +$1.88M | 0.07% | 24 |
|
|
2018
Q1 | $720K | Sell |
21,397
-27
| -0.1% | -$928 | 0.04% | 36 |
|
|
2017
Q4 | $737K | Buy |
21,424
+1,591
| +8% | +$54.3K | 0.04% | 36 |
|
|
2017
Q3 | $672K | Buy |
19,833
+32
| +0.2% | +$1.03K | 0.04% | 33 |
|
|
2017
Q2 | $631K | Sell |
19,801
-388
| -2% | -$12.2K | 0.04% | 35 |
|
|
2017
Q1 | $656K | Buy |
+20,189
| New | +$637K | 0.04% | 33 |
|
|
2016
Q3 | $662K | Buy |
20,615
+801
| +4% | +$26.8K | 0.04% | 35 |
|
|
2016
Q2 | $662K | Buy |
+19,814
| New | +$632K | 0.04% | 35 |
|
Other funds holding PFE
VCM
VPM
Members Trust's PFE Position: Q1 2026 in Review
Members Trust increased its Pfizer (PFE) stake by 0.82% in Q1 2026, buying an estimated $4.77K and bringing the position to 21,990 shares worth $617K. The position accounts for 0.02% of the portfolio, ranked #82.
Members Trust first reported a position in PFE in Q2 2016 and has held it in 31 quarters since. The position peaked at $1.72M in Q2 2020. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Members Trust held 21,990 shares of Pfizer worth $617K as of Q1 2026.
- Members Trust bought 179 Pfizer shares in Q1 2026, an estimated $4.77K.
- Pfizer made up 0.02% of Members Trust's portfolio in Q1 2026, its #82 holding.
- Members Trust first reported a position in Pfizer in Q2 2016 and has held it in 31 quarters since.
- Members Trust's Pfizer position peaked at $1.72M in Q2 2020.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Members Trust's 13F filing for Q1 2026, filed 4 May 2026.